Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,620 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
Cohen AT, Hamilton M, Mitchell SA, Phatak H, Liu X, Bird A, Tushabe D, Batson S. Cohen AT, et al. Among authors: hamilton m. PLoS One. 2015 Dec 30;10(12):e0144856. doi: 10.1371/journal.pone.0144856. eCollection 2015. PLoS One. 2015. PMID: 26716830 Free PMC article. Review.
Lifetime Clinical Events Avoided And Resource Utilization With Apixaban Compared To Low-Molecular-Weight Heparin Followed By A Vitamin K Antagonist For The Treatment And Prevention Of Venous Thromboembolism.
Hamilton M, Phatak H, Lanitis T, Mardekian J, Rublee DA, Leipold R, Quon P, Browne C, Cohen AT. Hamilton M, et al. Value Health. 2014 Nov;17(7):A475. doi: 10.1016/j.jval.2014.08.1358. Epub 2014 Oct 26. Value Health. 2014. PMID: 27201370 Free article. No abstract available.
Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
Cohen AT, Hamilton M, Bird A, Mitchell SA, Li S, Horblyuk R, Batson S. Cohen AT, et al. Among authors: hamilton m. PLoS One. 2016 Aug 3;11(8):e0160064. doi: 10.1371/journal.pone.0160064. eCollection 2016. PLoS One. 2016. PMID: 27487187 Free PMC article. Review.
Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice.
Weycker D, Li X, Wygant GD, Lee T, Hamilton M, Luo X, Vo L, Mardekian J, Pan X, Burns L, Atwood M, Hanau A, Cohen AT. Weycker D, et al. Among authors: hamilton m. Thromb Haemost. 2018 Nov;118(11):e1-e2. doi: 10.1055/s-0039-3400530. Epub 2020 Jan 27. Thromb Haemost. 2018. PMID: 31986533 Free PMC article. No abstract available.
Correction: Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.
Cohen AT, Hamilton M, Bird A, Mitchell SA, Li X, Horblyuk R, Batson S. Cohen AT, et al. Among authors: hamilton m. PLoS One. 2016 Sep 15;11(9):e0163386. doi: 10.1371/journal.pone.0163386. eCollection 2016. PLoS One. 2016. PMID: 27631606 Free PMC article.
2,620 results